Article Versions Notes

Neault N, Ravel-Chapuis A, Baird SD, Lunde JA, Poirier M, Staykov E, Plaza-Diaz J, Medina G, Abadía-Molina F, Jasmin BJ, et al. Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model. International Journal of Molecular Sciences. 2023; 24(4):3794. https://doi.org/10.3390/ijms24043794

Neault, Nafisa, Aymeric Ravel-Chapuis, Stephen D. Baird, John A. Lunde, Mathieu Poirier, Emiliyan Staykov, Julio Plaza-Diaz, Gerardo Medina, Francisco Abadía-Molina, Bernard J. Jasmin, and et al. 2023. "Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model" International Journal of Molecular Sciences 24, no. 4: 3794. https://doi.org/10.3390/ijms24043794

Neault, N., Ravel-Chapuis, A., Baird, S. D., Lunde, J. A., Poirier, M., Staykov, E., Plaza-Diaz, J., Medina, G., Abadía-Molina, F., Jasmin, B. J., & MacKenzie, A. E. (2023). Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model. International Journal of Molecular Sciences, 24(4), 3794. https://doi.org/10.3390/ijms24043794